Amphista Therapeutics funding
Amphista Therapeutics funding profile: $61M total raised. Latest round: Series B. Backed by Advent Life Sciences, Scottish Investment Bank, Scottish Growth Scheme.
Headquarters: Cambridge, England
Investors
- Advent Life Sciences
- Scottish Investment Bank
- Scottish Growth Scheme
- European Investment Fund
- BioMotiv
Fundraising guides
Browse the company funding database · Browse investors · Fundraising library
